Melatonin secretion starts in infants between 3 and 6 months of age, increases to maximal levels in early childhood, then decreases at puberty onset
Diabetes mellitus is a major metabolic disorder (Runthala et al., 2025) that is strongly associated with both macrovascular and microvascular complications, largely driven by platelet dysfunction (Kaur et al., 2018
& Lonsdorf, E
Haasch D, Berg C, Clampit JE, Pederson T, Frost L, Kroeger P, et al
However, the available research gives reason to be optimistic about the products in our guide
Some considerations and risks of long-term use include metabolic effects that could be changes in insulin sensitivity and cardiovascular effects that could shift blood pressure or lipid levels in vulnerable individuals